[1] |
Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer′s disease: recommendations from the National Institute on Aging-Alzheimer′s Association workgroups on diagnostic guidelines for Alzheimer′s disease[J]. Alzheimers Dement, 2011, 7(3):280-292.
doi: 10.1016/j.jalz.2011.03.003
pmid: 21514248
|
[2] |
Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer′s disease[J]. Alzheimers Dement, 2018, 14(4):535-562.
doi: 10.1016/j.jalz.2018.02.018
URL
|
[3] |
Charidimou A, Boulouis G, Greenberg SM, et al. Cortical superficial siderosis and bleeding risk in cerebral amyloid angiopathy: A meta-analysis[J]. Neurology, 2019, 93(24):e2192-e2202.
|
[4] |
Charidimou A, Frosch MP, Al-Shahi Salman R, et al. Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0[J]. Int J Stroke, 2019, 14(9):956-971.
doi: 10.1177/1747493019855888
pmid: 31514686
|
[5] |
Charidimou A, Jäger RH, Fox Z, et al. Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy[J]. Neurology, 2013, 81(7):626-62.
doi: 10.1212/WNL.0b013e3182a08f2c
pmid: 23864315
|
[6] |
中国医师协会神经内科分会脑与脊髓损害专业委员会. 慢性酒精中毒性脑病诊治中国专家共识[J]. 中华神经医学杂志, 2018, 17(1):2-9.
|
|
Neurology Committee of Brain and Spinal Cord Injury Branch, Chinese Medical Association. Consensus of Chinese experts on the diagnosis and treatment of chronic alcoholic encephalopathy[J]. Chin J Neuromed, 2018, 17(1):2-9.
|
[7] |
Arvanitakis Z, Leurgans SE, Wang Z, et al. Cerebral amyloid angiopathy pathology and cognitive domains in older persons[J]. Ann Neurol, 2011, 69(2):320-327.
doi: 10.1002/ana.22112
pmid: 21387377
|
[8] |
Ellis RJ, Olichney JM, Thal LJ, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer′s disease: the CERAD experience, Part XV[J]. Neurology, 1996, 46(6):1592-1596.
pmid: 8649554
|
[9] |
Pfeifer LA, White LR, Ross GW, et al. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study[J]. Neurology, 2002, 58(11):1629-1634.
pmid: 12058090
|
[10] |
Goos JD, Kester MI, Barkhof F, et al. Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition[J]. Stroke, 2009, 40(11):3455-3460.
doi: 10.1161/STROKEAHA.109.558197
URL
|
[11] |
Charidimou A, Zonneveld HI, Shams S, et al. APOE and cortical superficial siderosis in CAA: Meta-analysis and potential mechanisms[J]. Neurology, 2019, 93(4):e358-e371.
doi: 10.1212/WNL.0000000000007818
|
[12] |
Revesz T, Ghiso J, Lashley T, et al. Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view[J]. J Neuropathol Exp Neurol, 2003, 62(9):885-898.
doi: 10.1093/jnen/62.9.885
URL
|
[13] |
Greenberg SM, Al-Shahi Salman R, Biessels GJ, et al. Outcome markers for clinical trials in cerebral amyloid angiopathy[J]. Lancet Neurol, 2014, 13(4):419-428.
doi: 10.1016/S1474-4422(14)70003-1
pmid: 24581702
|
[14] |
Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, et al. Cerebral amyloid angiopathy and Alzheimer disease-one peptide, two pathways[J]. Nat Rev Neurol, 2020, 16(1):30-42.
doi: 10.1038/s41582-019-0281-2
pmid: 31827267
|